Update on dermatologic laser;Novedades en láser cutáneo

Actas Dermo-Sifiliograficas

Volumn 94, Issue 4, 2003, Pages 199-231

  Boixeda, Pablo ^a,b   Pérez Rodríguez, Alejandro ^a   Fernández Lorente, Manuel ^a   Arrazola, José María ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; CONGENITAL BLOOD VESSEL MALFORMATION; ERBIUM YAG LASER; EXCIMER LASER; HEMANGIOMA; HUMAN; LASER; NEODYMIUM LASER; NEVUS FLAMMEUS; PHOTODYNAMIC THERAPY; RADIOFREQUENCY RADIATION; REVIEW; SKIN DISEASE; TELANGIECTASIA; VASCULAR DISEASE;

EID: 0038039284     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(03)76675-7     Document Type: Review

References (433)

1. Nelson JS, Majaron B, Kelly KM. Active skin cooling in conjunction with laser dermatologic surgery. Semin Cutan Med Surg. 2000;19:253-66.
2. Nelson JS, Milner TE, Anvari B, Tanenbaum BS, Svaasand LO, Kimel S. Dynamic epidermal cooling in conjunction with laser-induced photothermolysis of port wine stain blood vessels. Lasers Surg Med 1996;19:224-9.
3. Chang CJ, Nelson JS. Cryogen spray cooling and higher fluence pulsed dye laser treatment improve port-wine stain clearance while minimizing epidermal damage. Dermatol Surg 1999;25:766-71.
4. Biesman BS. Efficacy and safety of skin-cooling devices. En: Controversies and conversations in cutaneous laser surgery. Chicago: Ama Press, 2002; p. 227-9.
5. Majaron B, Kimel S, Verkruysse W, Aguilar G, Pope K, Svaasand LO, et al. Cryogen spray cooling in laser dermatology: Effects of ambient humidity and frost formation. Lasers Surg Med 2001;28:469-76.
6. Nelson JS. Practical implementation of skin cooling. En: Controversies and conversations in cutaneous laser surgery. Ama Press 2002;219-22.
7. Anderson RR. Is skin cooling a bunch of hot air? En: Controversies and conversations in cutaneous laser surgery. Chicago: Ama Press, 2002; p. 223-5.
8. Pfefer TJ, Smithies DJ, Milner TE, Van Gemert MJC, Nelson JS, Welch AJ. Bioheat transfer analysis of cryogen spray cooling during laser treatment of port wine stains. Lasers Surg Med 2000;26:145-57.
9. Chang CJ, Anvari B, Nelson JS. Cryogen spray cooling for spatially selective photocoagulation of hemangiomas: A new methodology with preliminary clinical reports. Plast Reconstr Surg 1998;102:459-63.
10. Chang CJ, Kelly KM, Nelson JS. Cryogen spray cooling and pulsed dye laser treatment of cutaneous hemangiomas. Ann Plast Surg 2001;46:577-83.
11. Kelly KM, Nelson JS, Lask GP, Geronemus RG, Bernstein LJ. Cryogen spray cooling in combination with nonablative laser treatment of facial rhytides. Arch Dermatol 1999; 135:691-4.
12. Nelson JS, Milner TE, Dave D. Clinical study of non-ablative laser treatment of facial rhytides. Lasers Surg Med 1997;95:32-3.
13. Fatemi A, Weiss MA, Weiss RA. Short-term histologic effects of nonablative resurfacing: Results with a dynamically cooled millisecond-domain 1320 Nd:YAG laser. Dermatol Surg 2002;28:172-6.
14. Klavuhn KG, Green D. Importance of cutaneous cooling during photothermal epilation: Theoretical and practical considerations. Lasers Surg Med 2002;31:97-105.
15. Huang PS, Chang CJ. Cryogen spray cooling in conjunction with pulse dye laser treatment of port wine stains of the head and neck. Chang Gung Med J 2001;24:469-75.
16. Torres JH, Tunnell JW, Pikkula BM, Anvari B. An analysis of heat removal during cryogen spray cooling and effects of simultaneous airflow application. Lasers Surg Med 2001;28:477-86.
17. Verkruysse W, Majaron B, Tanenbaum BS, Nelson JS. Optimal cryogen spray cooling parameters for pulsed laser treatment of port wine stains. Lasers Surg Med 2000;27:165-70.
18. Kauvar ANB, Lou WW, Zelickson B. Effect of cryogen spray cooling on 595 nm, 1.5 ms pulsed dye laser treatment of port wine stains. Lasers Surg Med 2000;(Suppl 12):24.
19. Kelly KM, Nanda VS, Shirin S, Nelson JS. Vascular lesion treatment utilizing a pulsed dye laser at high fluences in combination with cryogen spray cooling. Lasers Surg Med 2000;(Suppl 12):26.
20. Aguilar G, Díaz SH, Lavernia EJ, Nelson JS. Cryogen spray cooling efficiency: Improvement of port wine stain laser therapy through multiple-intermittent cryogen spurts and laser pulses. Lasers Surg Med 2002;31:27-35.
21. Kelly KM, Nanda VS, Nelson JS. Treatment of port-wine stain birthmarks using the 1.5-msec pulsed dye laser at high fluences in conjunction with cryogen spray cooling. Dermatol Surg 2002;28:309-13.
22. Aguilar G, Majaron B, Pope K, Svaasand LO, Lavernia EJ, Nelson JS. Influence of nozzle-to-skin distance in cryogen spray cooling for dermatologic laser surgery. Lasers Surg Med 2001;28:113-20.
23. Anvari B, Ver Steeg BJ, Milner TE, Tanenbaum BS, Klein TJ, Gerstner E, et al. Cryogen spray cooling of human skin: Effects of ambient humidity level, spraying distance, and cryogen boiling point. Proc SPIE 1997;3192:106-10.
24. Zenzie HH, Altshuler GB, Smirnov MZ, Anderson RR. Evaluation of cooling methods for laser dermatology. Lasers Surg Med 2000:26;130-44.
25. Bjerring P. Termal imaging and theoretical modeling in skin cooling. En: Controversies and conversations in cutaneous laser surgery. Chicago: Ama Press, 2002; p. 213-7.
26. Raulin C, Greve B, Hammes S. Cold air in laser therapy: First experiences with a new cooling system. Lasers Surg Med 2000;27:404-10.
27. Greve B, Hammes S, Raulin C. The effect of cold air cooling on 585 nm pulsed dye laser treatment of port-wine stains. Dermatol Surg 2001;27:633-6.
28. Gilchrest BA, Rosen S, Noe J. Chilling port wine stains improves the response to argon laser therapy. Plast Reconstr Surg 1982;69:278-83.
29. Nelson JS, Milner TE, Anvari B, Tanenbaum BS, Kimel S, Svaasand LO, et al. Dynamic epidermal cooling during pulsed laser treatment of port-wine satín. Arch Dermatol 1995;131:695-700.
30. Chang CJ, Kelly KM, Van Gemert MJC, Nelson JS. Comparing the effectiveness of 585-nm vs. 595-nm wavelength pulsed dye laser treatment of port wine stains in conjunction with cryogen spray cooling. Lasers Surg Med 2002;31: 352-8.
31. Geronemus RG, Quintana AT, Lou WW, Kauvar ANB. High-fluence modified pulsed dye laser photocoagulation with dynamic cooling of port-wine stains in infancy. Arch Dermatol 2000;136:942-3.
32. Fader DJ, Sax DS, Hamilton TA. Quantifying postoperative pain reduction using the dynamic cooling device to treat pediatric patients with port-wine stains. Arch Dermatol 2000;136:1416-7.
33. Tunnell JW, Nelson JS, Torres JH, Anvari B. Epidermal protection with cryogen spray cooling during high fluence pulsed dye laser irradiation: An ex vivo study. Lasers Surg Med 2000;27:373-83.
34. Verkruysse W, Majaron B, Aguilar G, Svaasand LO, Nelson JS. Dynamics of cryogen deposition relative to heat extraction rate during cryogen spray cooling. Proc SPIE 2000; 3907:37-8.
35. Aguilar G, Verkruysse W, Majaron B, Svaasand LO, Lavernia EJ, Nelson JS. Measurement of heat flux and heat transfer coefficient during continuous cryogen spray cooling for laser dermatologic surgery. IEEE J Sel Top Quant 2001;7:1013-21.
36. Pikkula BM, Torres JH, Tunnell JW, Anvari B. Cryogen spray cooling: Effects of droplet size and spray density on heat removal. Lasers Surg Med 2001;28:103-12.
37. Buscher BA, Thomas O, McMeekin TO, Goodwin D. Treatment of leg telangiectasia by using a long-pulse dye laser at 595 nm with and without dynamic cooling device. Lasers Surg Med 2000;27:171-5.
38. Kauvar ANB, Frew KE, Friedman PM, Geronemus RG. Cooling gel improves pulsed KTP laser treatment of facial telangiectasia. Lasers Surg Med 2002;30:149-53.
39. Eremia S, Li CY, Umar SH. A side-by-side comparative study of 1064 nm Nd:YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3-3 mm leg veins. Dermatol Surg 2002;28:224-30.
40. Varma S, Lanigan SW. Laser therapy of telangiectatic leg veins: Clinical evaluation of the 810 nm diode laser. Clin Exp Dermatol 2000;25:419-22.
41. Sadick NS. Long term results with a multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins. Dermatol Surg 2001;27: 365-9.
42. Rogachefsky AS, Becker K, Weiss G, Goldberg DJ. Evaluation of a long-pulsed Nd:YAG laser at different parameters: An analysis of both fluence and pulse duration. Dermatol Surg 2002;28:932-6.
43. Ross EV, Ladin Z, Kreindel M, Dierickx C. Theoretical considerations in laser hair removal. Dermatol Clinics 1999;17:333-55.
44. Nahm WK, Tsoukas MM, Falanga V, Carson PA, Sami N, Touma DJ. Preliminary study of fine changes in the duration of dynamic cooling during 755-nm laser hair removal on pain and epidermal damage in patients with skin types III-V. Lasers Surg Med 2002;31:247-51.
45. Richards KA, Garden JM. The pulsed dye laser for cutaneous vascular and nonvascular lesions. Semin Cutan Med Surg 2000;19:276-86.
46. Boixeda P. Treatment with millisecond domain lasers of port wine stains and facial telangiectasia. «Controversies and Conversations in cutaneous laser surgery». Chicago: Ama Press, 2002; p. 125-43.
47. Scherer K, Lorenz S, Wimmershoff M, Landthaler M, Hohenleutner U. Both the flashlamp-pumped dye laser and the long-pulsed tunable dye laser can improve results in port-wine stain therapy. Br J Dermatol 2001;145:79-84.
48. Chang CJ, Kelly KM, Van Gemert MJ, Nelson JS. Comparing the effectiveness of 585-nm vs. 595-nm wavelength pulsed dye laser treatment of port wine stains in conjunction with cryogen spray cooling. Lasers Surg Med 2002;31: 352-8.
49. Dierickx CC, Casparian JM, Venugopalan V, Farinelli WA, Anderson RR. Thermal relaxation of port-wine stain vessels probed in vivo: The need for 1-10-millisecond laser pulse treatment. J Invest Dermatol 1995;105:709-14.
50. Lou WW, Geronemus RG. Treatment of port-wine stains by variable pulse width pulsed dye laser with cryogen spray: A preliminary study. Dermatol Surg 2001;27:963-5.
51. Shah NS, Lazarus MC, Bugdodel R, Hsia SL, He J, Duncan R, et al. The effects of topical vitamin K on bruising after ñaser treatment. J Am Acad Dermatol 2002;47:241-4.
52. Dover JS, Arndt KA. New approaches to the treatment of vascular lesions. Lasers Surg Med 2000;26:158-63.
53. Adrian RM, Tanghetti EA. Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg 1998;24:71-4.
54. Goodman GJ, Roberts S, Bezborodoff A. Studies in long-pulsed potassium tritanyl phosphate laser for the treatment of spider naevi and perialar telangiectasia. Australas J Dermatol 2002;43:9-14.
55. Hercogova J, Brazzini B, Hautmann G, Ghersetich I, Lotti T. Laser treatment of cutaneous vascular lesions: Face and leg telangiectases. J Eur Acad Dermatol Venereol 2002;16: 12-8.
56. Kauvar AN. The role of lasers in the treatment of leg veins. Semin Cutan Med Surg 2000;19:245-52.
57. Goldman MP. Laser and sclerotherapy treatment of leg veins: My perspective on treatment outcomes. Dermatol Surg 2002;28:969.
58. Lupton JR, Alster TS, Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol Surg 2002;28:694-7.
59. Weiss RA, Dover JS. Laser surgery of leg veins. Dermatol Clin 2002;20:19-36.
60. Dover JS, Sadick NS, Goldman MP. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg 1999;25:328-35.
61. Alora MB, Stern RS, Arndt KA, Dover JS. Comparison of the 595 nm long-pulse (1.5 msec) and ultralong-pulse (4 msec)lasers in the treatment of leg veins. Dermatol Surg 1999;25:445-9.
62. Spendel S, Prandl EC, Schintler MV, Siegl A, Wittgruber G, Hellbom B, et al. Treatment of spider leg veins with the KTP (532 nm) laser-a prospective study. Lasers Surg Med 2002;31:194-201.
63. Fournier N, Brisot D, Mordon S. Treatment of leg telangiectases with a 532 nm KTP laser in multipulse mode. Dermatol Surg 2002;28:564-71.
64. Brunnberg S, Lorenz S, Landthaler M, Hohenleutner U. Evaluation of the long pulsed high fluence alexandrite laser therapy of leg telangiectasia. Lasers Surg Med 2002;31:359-62.
65. Kaudewitz P, Klovekorn W, Rother W. Effective treatment of leg telangiectasia with a new diode laser. Dermatol Surg 2001;27:101-6.
66. Sadick NS, Weiss R. The utilization of a new yellow ligh laser (578 nm) for the treatment of class I red telangiectasia of the lower extremities. Dermatol Surg 2002;28:21-5.
67. Goldman MP. Treatment of leg veins with lasers and intense pulsed light. Preliminary considerations and a review of present technology. Dermatol Clin 2001;19:467-73.
68. Sadick NS. A dual wavelength approach for laser/intense pulsed light source treatment of lower extremity veins. J Am Acad Dermatol 2002;46:66-72.
69. Rogachefsy AS, Silapunt S, Goldberg MP. Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: Efficacy as measured by vessel color and size. Dermatol Surg 2002;28:220-2.
70. Eremia S, Li CY. Treatment of leg and face veins with a cryogen spray variable pulse with 1064-nm Nd:YAG laser - a prospective study of 47 patients. J Cosmet Laser Ther 2001;3:147-53.
71. Coles CM, Werner RS, Zelickson BD. Comparative pilot study evaluating the treatment of leg veins with a long pulse Nd:YAG laser and sclerotherapy. Lasers Surg Med 2002; 30:154-9.
72. Omura NE, Dover JS, Arndt KA, Kauvar AN. Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser. J Am Acad Dermatol 2003;48:76-81.
73. Eremia S, Li C, Umar SH. A side-by-side comparative study of 1064 nm Nd:YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3-3 mm leg veins. Dermatol Surg 2002;28:224-30.
74. Sadick NS, Weiss RA, Goldman MP. Advances in laser surgery for leg veins: Bimodal wavelength approach to lower extremity vessels, new cooling techniques, and longer pulse durations. Dermatol Surg 2002;28:16-20.
75. Chang CJ, Chua JJ. Endovenous laser photocoagulation (EVLP) for varicose veins. Lasers Surg Med 2002;31:257-62.
76. Navarro L, Min RJ, Bone C. Endovenous laser: A new minimally invasive method of treatment for varicose veins-preliminary observations using an 810 nm diode laser. Dermatol Surg 2001;27:117-22.
77. Weiss RA. Endovenous techniques for elimination of saphenous reflux: A valuable treatment modality. Dermatol Surg 2001;27:902-5.
78. Kauvar ANB, Gossman MC, Bernstein LJ, Kovacs SO, Quintana AT, Geronemus RG. The effect of cryogen spray cooling on pulsed dye laser treatment of vascular lesions (abstract). Lasers Surg Med 1998;(Suppl 10):211.
79. Geronemus RG, Quintana AT, Lou WW, Kauvar AN. High-fluence modified pulsed dye laser photocoagulation with dynamic cooling of port-wine stains in infancy. Arch Dermatol 2000;136:942-3.
80. Majaron B, Verkruysse W, Tanenbaum BS, Milner TE, Telenkov SA, Goodman DM, et al. Combining two excitation wavelengths for pulsed photothermal profiling of hypervascular lesions in human skin. Phys Med Biol 2000;45:1913-22.
81. Torres JH, Tunnell JW, Pikkula BM. Anvari B an analysis of heat removal during cryogen spray cooling and effects of simultaneous airflow application. Lasers Surg Med 2001;28:477-86.
82. Koster PH, Van der Horst CM, Bossuyt PM, Van Gemert MJ. Prediction of portwine stain clearance and required number of flashlamp pumped pulsed dye laser treatments. Lasers Surg Med 2001;29:151-5.
83. Núñez Cabezón M. Tratamiento del Nevus Flammeus con láser de colorante pulsado: Resultado y factores pronósticos [tesis doctoral]. Alcalá de Henares, 2002.
84. Fiskerstrand EJ, Svaasand LO, Kopstad G, Dalaker M, Norvang LT, Volden G. Laser treatment of port wine stains: Therapeutic outcome in relation to morphological parameters. Br J Dermatol 1996;134:1039-43.
85. Kelly KM, Nanda VS, Nelson JS. Treatment of port-wine stain birthmarks using the 1.5-msec pulsed dye laser at high fluences in conjunction with cryogen spray cooling. Dermatol Surg 2002;28:309-13.
86. Loo WJ, Lanigan SW. Recent advances in laser therapy for the treatment of cutaneous vascular disorders. Lasers Med Sci 2002;17:9-12.
87. Lou WW, Geronemus RG. Dermatologic laser surgery. Semin Cutan Med Surg 2002;21:107-28.
88. Greve B, Hammes S, Raulin C. The effect of cold air cooling on 585 nm pulsed dye laser treatment of port-wine stains. Dermatol Surg 2001;27:633-6.
89. Bernstein EF. Treatment of a resistant port-wine stain with the 1.5-msec pulse duration, tunable, pulsed dye laser. Dermatol Surg 2000;26:1007-9.
90. Kimel S, Svaasand LO, Cao D, Hammer-Wilson MJ. Vascular response to laser photothermolysis as a function of pulse duration, vessel type, and diameter: Implications for port wine stain therapy. Lasers Surg Med 2002;30:160-9.
91. Bencini PL. The multilayer technique: A new and fast approach for flashlamp-pumped pulsed (FLPP) dye laser treatment of port-wine stains (preliminary reports). Dermatol Surg 1999;25:786-9.
92. Lorenz S, Brunnberg S, Landthaler M, Hohenleutner U. Regarding the multilayer technique for treatment of PWS. Dermatol Surg. 2001;27:90
93. Verkruysse W, Van Gemert MJ, Smithies DJ, Nelson JS. Modelling multiple laser pulses for port wine stain treatment. Phys Med Biol 2000;45:N197-203.
94. Aguilar G, Díaz SH, Lavernia EJ, Nelson JS. Cryogen spray cooling efficiency: Improvement of port wine stain laser therapy through multiple-intermittent cryogen spurts and laser pulses. Lasers Surg Med 2002;31:27-35.
95. Raulin C, Schroeter CA, Weiss RA, Keiner M, Werner S. Treatment of port-wine stains with a noncoherent pulsed light source: A retrospective study. Arch Dermatol 1999;135:679-83.
96. Cliff S, Misch K. Treatment of mature port wine stains with the PhotoDerm VL. J Cutan Laser Ther 1999;1:101-4.
97. Angermeier MC. Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther 1999;1:95-100.
98. Chowdhury MMU, Harris S, Lanigan SW. Potassium titanyl phosphate laser treatment of resistant port wine stains. Br J Dermatol 2001;144:814-7.
99. 2 laser vaporization. Dermatol Surg 2001;27:699-702.
100. Le KV, Shahidullah H, Frieden IJ. Review of modern techniques in detecting port-wine stain response to laser therapy. Dermatol Surg 1999;25:127-32.
101. Rah DK, Kim SC, Lee KH, Park BY, Kim DW. Objective evaluation of treatment effects on port-wine stains using L*a*b* color coordinates. Plast Reconstr Surg 2001;108:842-7.
102. Troilius A, Svendsen G, Ljunggren. Ultrasound investigation of port wine stains. Acta Derm Venereol 2000;80:196-9.
103. Procaccini EM, Argenziano G, Staibano S, Ferrara G, Monfrecola G. Epiluminescence microscopy for port-wine stains: Pretreatment evaluation. Dermatology 2001;203:329-32.
104. Eubanks LE, McBurney EI. Videomicroscopy of port wine stains: Correlation of location and depth of lesion. J Am Acad Dermatol 2001;44:948-51.
105. Yong-Gee SA, Kurwa HA, Barlow RJ. Objective assessment of port-wine stains following treatment with the 585 nm pulsed dye laser. Australas J Dermatol 2001;42:243-6.
106. Lanigan SW. Measuring the improvement in pulsed dye laser treated port wine stains. Br J Dermatol 2000;143:241-3.
107. Currie CL, Monk BE. Can the response of port-wine stains to laser treatment be reliably assessed using subjective methods? BrJ Dermatol 2000;143:360-4.
108. Stuart Nelson J, Kelly KM, Zhao Y, Chen Z. Imaging blood flow in human port-wine stain in situ and in real time using optical doppler tomography. Arch Dermatol 2001; 137:741-4.
109. Majaron B, Verkruysse W, Tanenbaum BS, Milner TE, Telenkov SA, Goodman DM, et al. Combining two excitation wavelegths for pulsed photothermal profiling of hypervascular lesions in human skin. Phys Med Biol 2000;45: 1913-22.
110. Viator JA, Au G, Paltauf G, Jacques SL, Prahl SA, Ren H, et al. Clinical testing of a photoacoustic probe for port wine stain depth determination. Lasers Surg Med 2002;30:141-8.
111. Kauvar ANB, Kist D, Friedman P, Geronemus RG, Zelickson B. Confocal microscopic study examining the effect of wavelength pulse duration and fluence in laser treatment of port wine stains (abstract). Lasers Surg Med 2001; (Suppl 13):26.
112. Poetke M, Philipp C, Berlien HP. Treatment of hemangiomas in infancy and childhood with the flash lamp-pumped dye laser: Cutaneous versus mixed cutaneous-subcutaneous hemangiomas. Hautarzt 2001;52:120.
113. Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R. Randomized controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: Results of a 1-year analysis. Lancet 2002;360:521-7.
114. Sevila A, Botella-Estrada R, Nagore E, Sanmartín O, Guillén C. Valoración del tratamiento de los hemangiomas infantiles ulcerados. Actas Dermosifiliogr 2002;93:340-3.
115. Raulin C, Greve B. Retrospective clinical comparison of hemangioma treatment by flashlamp-pumped (585 nm) and frequency-doubled Nd:YAG (532 nm) lasers. Lasers Surg Med 2001;28:40-3.
116. Langeland J. Treatment of poikiloderma of Civatte with the pulsed dye laser: A series of seven cases. J Cutan Laser Ther 1999;1:127.
117. Goldman MP, Weiss RA. Treatment of poikiloderma of Civatte on the neck with an intense pulsed light source. Plast Reconstr Surg 2001;107:1376-81.
118. Weiss RA, Goldman MP, Weiss MA. Treatment of poikiloderma of Civatte with an intense pulsed light source. Dermatol Surg 2000;26:823-7.
119. Clark SM, Lanigan SW, Marks R. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci 2002;17:26-33.
120. Batta K, Hindson C, Cotterill JA, Foulds IS. Treatment of poikiloderma of Civatte with the potassium titanyl phosphate (KTP) laser. Br J Dermatol 1999;140:1191-2.
121. Raulin C, Werner S. Treatment of venous malformations with an intense pulsed light source (IPLS) technology: A retrospective study. Lasers Surg Med 1999;25:170-7.
122. Anderson RR, Margolis RJ, Watanabe S, Flotte TJ, Hruza GJ, Dover J. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532 and 355 nm. J Invest Dermatol 1989;93:28-32.
123. Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-7.
124. Stratigos A, Dover JS, Arndt KA. Laser treatment of pigmented lesions-2000: How far have we gone? Arch Dermatol 2000;136;915-21.
125. Anderson RR. Regarding tattoos. Is that sunlight, or an oncoming train at the end of the tunnel? Arch Dermatol 2001;137;210-2.
126. Polla LL, Margolis RJ, Dover JS, Whitaker D, Murphy GF, Jacques SL. Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol 1987;89:281-6.
127. Dover JS, Polla LL, Margolis RJ, et al. Pulse width dependence of pigment cell damage at 694 nm in guinea pig skin. SPIE Lasers Med 1986;712:200-5.
128. Taylor CR, Anderson RR, Gange RW, Michaud NA, Flotte TJ. Light and electron microscopic analysis of tattoos treated by Q-switched ruby laser. J Invest Dermatol 1997; 97:131-6.
129. Dover JS, Margolis RJ, Polla LL, Whanabe S, Sher CR, Hruza GJ. Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses: Morphologic and histologic findings. Arch Dermatol 1989;125:43-9.
130. Ort RJ. Tattoos and their treatments. Med Surg Dermatol 1998;5:265-8.
131. Ara G, Anderson RR, Mandel KG, Ottessen M, Oseroff AR. Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kills cells. Lasers Surg Med 1990;10:52-9.
132. Herd RM, Alora MB, Smoller B, Arndt KA, Dover JS. A clinical and histologic prospective controlled comparative study of the picosecond titanium: Sapphire (795 nm) laser versus the Q-switched alexandrite (752 nm) laser for removing tattoo pigment. J Am Acad Dermatol 1999;40: 603-6.
133. Ross V, Naseef G, Lin G, Kelly M, Michaud N, Flotte TJ, et al. Comparison of responses of tattoos to picosecond and nanosecond Q-switched Nd:YAG lasers. Arch Dermatol 1998;134:167-71.
134. Grevelink JM, Leewen RL, Anderson RR, Byers R. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch Dermatol 1997;133:349-53.
135. Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmentary lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminium-garnet laser: A comparative study. J Dermatol Surg Oncol 1994;20:795-800.
136. Alster, Grekin RC, Shelton RM, Geisse JK, Frieden I. 510 nm pigmented lesion dye laser. Its characteristics and clinical uses. J Dermatol Surg Oncol 1993;19:380-7.
137. Weiss RA, Goldman MP, Weiss MA. Treatment of Poikiloderma of Civatte with an intense pulsed light source. Dermatol Surg 2000;26:823-8.
138. Gold MH, Foster TD, Bell MW. Nevus spilus successfully treated with an intense pulsed light source. Dermatol Surg 1999;25:254-5.
139. Moreno-Arias GA, Ferrando J. Noncoherent-Intense-Pulsed Light for the treatment of relapsing hairy intradermal melonocytic nevus after shave excision. Lasers Surg Med 2001;29:142-4.
140. Moreno-Arias GA, Ferrando J. Intense pulsed light for melanocytic lesions. Dermatol Surg 2001;27:397-400.
141. Goldstein N, Penoff J, Price N, Celley RI, Goldman L, Hayroe V. Techniques of removal of tattoos. J Dermatol Surg Oncol 1979;5:901-10.
142. Ross EV. Removal of dermal pigment and tattoos: Can't we do better. En: Controversies and conversations in cutaneous laser surgery. Ojai (California) 2002;309-15.
143. Kilmer SL, Anderson RR. Clinical use of the Q-switched ruby and the Q-switched Nd:YAG (1064 and 532 nm) lasers for treatment of tattoos. J Dermatol Surg Oncol 1993;19:330-8.
144. Stafford TJ, Tan OT. 510 nm pulsed dye laser and alexandrite crystal laser for the treatment of pigmented lesions and tattoos. Clin Dermatol 1995;13:69-73.
145. Moreno-Arias GA, Casals-Andreu M, Camps-Fresneda A Use of Q-switched alexandrite laser (755 nm, 100 nsec) for removal of traumatic tattoo of different origins. Lasers Surg Med 1999;25:445-50.
146. Goyal S, Arndt KA, Stern RS, O'Hare D, Dover JS. Laser treatment of tattoos; a prospective, paired comparison study of the Q-switched Nd:YAG (1064 nm), frequency doubled Nd:YAG (532 nm) and Q-switched ruby lasers. J Am Acad Dermatol 1997;36:122-5.
147. Kilmer SL, Lee MS, Grevelink JM, Flotte TJ, Anderson RR. The Q-switched Nd:YAG laser effectively treats tattoos: A controlled, dose-response study. Arch Dermatol 1993;129:971-8.
148. Jones A, Roddey P, Orengo I, Rosen T. The Q-switched Nd:YAG laser effectively treats tattoos in darkly pigmented skin. Dermatol Surg 1996;22:999-1001.
149. Grevelink JM, Duke D, Van Leeuwen RL, González E, DeCoste SD, Anderson RR. Laser treatment of tattoos in darkly pigmented patients: Efficacy an side effects. J Am Acad Dermatol 1996;34;653-6.
150. Kilmer SL. Laser treatment of tattoos. Dermatol Clin 1997;15:409-17.
151. Varma S, Swanson NA, Lee KK. Tattoo ink darkening of a yellow after Q-switched laser treatment. Clin Exp Dermatol 2002;27:461-3.
152. Anderson RR, Geronemus R, Kilmer SL, Farinelli W, Fitzpatrick RE. Cosmetic tattoo ink darkening: A complication of Q-switched and pulsed laser treatment. Arch Dermatol 1993;129:1010-4.
153. Timko AL, Miller C, Johnson F, Ross EV. In vitro quantitative chemical analysis of tattoo pigments. Arch Dermatol 2001;137:143-7.
154. Ross EV, Yashar S, Michaud N, Fitzpatrick R, Geronemus R, Tope WD, et al. Tattoo Darkening and Nonresponse After Laser Treatment: A Possible Role for Titanium Dioxide. Arch Dermatol 2001;137:33-7.
155. Huzaira M, Anderson RR. Magnetite tattoos. Lasers Surg Med 2002;31;121-8.
156. Tope WD. Resistance of tattoos to the Q-switched laser. En: Controversies and conversations in cutaneous laser surgery. Ojai (California) 2002;303-7.
157. Ho DD, London R, Zimmerman GB, Young DD. Laser-tattoo removal, a study of the mechanism and the optimal treatment strategy via computer simulations. Lasers Surg Med 2002;30:389-97.
158. Kobayasi H, Togashi K. CT of tattoos removed with laser therapy. AJR Am J Roentgenol 2000;174:1468-69.
159. Mosquera O. Tratamiento de lesiones pigmentadas y tatuajes con luz pulsada intensa. En: Cisneros Vela JL, Camacho Martínez F, editores. Lβser y fuentes de luz pulsada en dermatología y dermocosmética. Madrid: Aula Médica, 2000.
160. Colver GB, Cherry GW, Dawber RPR, Ryan TJ. Tattoo removal using infra-red coagulation. Br J Dermatol 1985; 112:481-5.
161. 2 laser resurfacing of tattoos prior to Q-switched laser treatment. Lasers Surg Med 2000;23(Suppl 12).
162. Spicer MS, Goldberg DJ. Lasers in dermatology. J Am Acad Dermatol 1996;34:1-25.
163. Taylor CR, Anderson RR. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Int J Dermatol 1993;32:908-12.
164. Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. Laser treatment of benign pigmented epidermal lesions using a 300-nanosecond pulse and a 510-nm wavelength. J Dermatol Surg Oncol 1993;18:341-7.
165. Goldberg DJ. Benign pigmented lesions of the skin: Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol 1993;19:376-9.
166. Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser: A controlled, single-impact, dose-response, multicenter trial. Arch Dermatol 1994;130:1515-9.
167. Suh DH, Han KH, Chung JH. The use of Q-switched Nd:YAG laser in the treatment of superficial pigmented lesions in Koreans. J Dermatolog Treat 2001;12:91-6.
168. Todd MM, Rallis TM, Gerwels JW, Hata TR. A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines. Arch Dermatol 2000;136:841-6.
169. Li YT, Yang KC. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines. Dermatol Surg 1999;25: 202-4.
170. Grevelink JM, Casparian JM, González E, Momtaz K, DeCorte SD, Grassi AM. Undesirable side effects associated with treatment of tattoos and pigmented lesions with Q-switched lasers at 1064 nm and 694 nm: The MGH experience. Lasers Surg Med 1993;(Suppl 5):56.
171. Rosenbach A. Treatment of médium-brown solar lentigines using an alexandrite laser designed for hair reduction. Arch Dermatol 2002;138;547-8.
172. Grossman MC, Anderson RR, Farinelli W, Flotte TJ, Grevelink JM. Treatment of cafe au lait macules with lasers: A clinicopathologic correlation. Arch Dermatol 1995;131: 1416-20.
173. Shimbashi T, Kamide R, Hashimoto T. Long-term follow-up in treatment of solar lentigo and café-au-lait macules with Q-switched ruby laser. Aesthetic Plast Surg 1997;21:445-8.
174. Alster TS. Complete elimination of large cafe-au-lait birthmarks by the 510-nm pulsed dye laser. Plast Reconstr Surg 1995;96:1660-4.
175. Somyos K, Boonchu K, Somsak K, Panadda L, Leopairut J. Copper vapour laser treatment of café-au-lait macules. Br J Dermatol 1996;135:964-8.
176. Alora MB, Arndt KA. Treatment of a cafθ-au-lait macule with the erbium:YAG laser. J Am Acad Dermatol 2001;45:565-8.
177. Grevelink JM, González S, Bonoan R, Vibhagool G, González E. Treatment of nevus spilus with the Q-switched ruby laser. J Dermatol Surg 1997;23:365-70.
178. Nelson JS, Applebaum J. Treatment of superficial cutaneous pigmented lesions by melanin-specific selective phototermolysis using the Q-switched ruby laser. Ann Plast Surg 1992;29:231-7.
179. Tan OT, Morelli JG, Kurban AK. Pulsed dye laser treatment of benign cutaneous pigmented lesions. Lasers Surg Med 1992;12:538-42.
180. Moreno-Arias GA, Bulla F, Vilata-Corell JJ, Camps-Fresneda A. Treatment of widespread segmental nevus spilus by Q-switched alexandrite laser (755 nm 100 nsec). Dermatol Surg 2001;27:841-3.
181. Van Leeuwen RL, Bastiaens MT, Grevelink JM. Management of nevus spilus with laser. Pediatr Dermatol 1996; 14:155-6.
182. Kopera D, Hohenleutner U, Landthaler M. Quality-switched ruby laser treatment of solar lentigines and Becker's nevus: A histopathological and immunochemical study. Dermatology 1997;194:338-43.
183. Nanni CA, Alster TS. Treatment of a Becker's nevus using a 694-nm long-pulsed ruby laser. Dermatol Surg 1998;24: 1032-4.
184. Grevelink JM. Laser treatment of pigmented structures in the skin (doctoral thesis). Leiden, the Netherlands, University of Leiden, 1997.
185. Apfelberg DB. Argon and Q-switched yttrium-aluminium-garnet laser treatment of nevus of Ota. Ann Plast Surg 1995;35:150-3.
186. Taylor CR, Flotte TJ, Gange RW, Anderson RR. Treatment of nevus of Ota by Q-switched ruby laser. J Am Acad Dermatol 1994;30:743-51.
187. Geronemus RG. Q-switched ruby laser therapy of nevus of Ota. Arch Dermatol 1992;128:1618-22.
188. Lowe NJ, Wieder JM, Sawcer D, Burrows P, Chalet M. Nevus of Ota: Treatment with high energy fluences of the Q-switched ruby laser. J Am Acad Dermatol 1993;29:997-1001.
189. Kono T, Nozaki M, Chan H, Mikashima Y. A retrospective study looking at the long-term complications of Q-switched ruby laser in the treatment of nevus of Ota. Lasers Surg Med 2001;29:156-9.
190. Shimbashi T, Hykusoku H, Okinaga M. Treatment of nevus of Ota by Q-switched ruby laser. Aesthetic Plast Surg 1997;21:118-21.
191. Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. N Engl J Med 1994;331:1745-50.
192. Chang CJ, Nelson JS, Achauer BM. Q-switched ruby laser treatment of oculodermal malenosis (nevus of Ota). Plast Reconstr Surg 1996;98:784-90.
193. Alster TS, Williams CS. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol Surg 1995;21:592-6.
194. Moreno-Arias GA, Camps-Fresneda A. Treatment of nevus of Ota with the Q-switched alexandrite laser. Lasers Surg Med 2001;28:451-5.
195. Hakozaki M, Masuda T, Oikawa H, Nara T. Light and electron microscopic investigation of the process of healing of the naevus of Ota by the Q-switched alexandrite laser irradiation. Virchows Arch 1997;431:63-71.
196. Chan HH, Ying SY, Ho WS, Kono T, King WW. An in vivo trial comparing the clinical efficacy and compliations of Q-switched 755 nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota. Dermatol Surg 2000;26:919-22.
197. Chan HH, Leung RS, Ying SY, Lai CF, Kono T, Chua JK. A retrospective analysis of complications in the treatment of nevus of Ota with the Q-switched alexandrite and Q-switched lasers. Dermatol Surg 2002;26:1000-6.
198. Ueda S, Isoda M, Imayama S. Response of nevus of Ota to Q-switched ruby laser treatment according to lesion colour. Br J Dermatol 2000;142:77-83.
199. Kang W, Lee E, Choi GS. Treatment of Ota's nevus by Q-switched alexandrite laser: Therapeutic outcome in relation to clinical and histopathologic findings. Eur J Dermatol 1999;9:639-43.
200. Chan HH, Lam L, Wong DSY, Leung RSC, Ying S, Lai C, et al. Nevus de Ota: A new classification based on the response to Laser treatment. Lasers Surg Med 2001;28: 262-72.
201. Chan HH. Tattoos and dermal pigment: What is new and what is next? Controversies and conversations in cutaneous laser surgery. Ojai (California) August 9-11. 2002; (personal communication).
202. Hohenleutner U, Landthailer M. Laser therapy of verrucous epidermal naevi. Clin Exp Dermatol 1993;18:124-7.
203. Hohenleutner U, Wlotzke U, Konz B, Landthaler M. Carbon dioxide laser therapy of a widespread epidermal nevus. Lasers Surg Med 1995;16:288-91.
204. Kaufmann R, Hibst R. Pulsed erbium:YAG laser ablation in cutaneous surgery. Lasers Surg Med 1996;19:324-30.
205. 2 laser treatment of epidermal nevi: Long-term success. Dermatol Surg 2002;28:611-4.
206. Baba T, Narumi H, Hanada K, Hashimoto I. Successful treatment of dark-colored epidermal nevus with ruby laser. J Dermatol 1995;22:567-70.
207. Ohtsuka H, Nakaoka H, Watanabe T, Okayama N. Ruby laser treatment of pigmented skin lesions. Jpn J Plast Reconstr Surg 1991;34:615-23.
208. Alster TS. Inflammatory linear verrucous epidermal nevus: Successful treatment with the 585 nm flashlamp-pumped dye laser. J Am Acad Dermatol 1994;31:513-4.
209. Waldorf HA, Kauvar AN, Geronemus RG. Treatment of small and medium congenital nevi with the Q-switched ruby laser. Arch Dermatol 1996;132:301-4.
210. Duke D, Byers HR, Sober AJ, Anderson RR, Grevelink JM. Treatment of benign and atypical nevi with the normal mode ruby laser and the Q-switched ruby laser. Arch Dermatol 1999;135:290-6.
211. Rosenbach A, Williams CM, Alster TS. Comparison of the Q-switched alexandrite (755 nm) and Q-switched Nd:YAG (1064 nm) lasers in the treatment of benign melanocytic nevi. Dermatol Surg 1997;23:239-44.
212. Goldberg DJ, Stampien T. Q-switched ruby laser treatment of congenital nevi. Arch Dermatol 1995;131:621-3.
213. Levins PC, Anderson RR. Q-switched ruby laser for the treatment of pigmented lesions and tattoos. Clin Dermatol 1995;13:75-9.
214. Ken-ichiro K, Hisano A, Yoshitaka F. An analysis of 300 patients with congenital pigmented nevus who underwent laser treatment and a proposal of serial treatment-Osaka procedure. Lasers Surg Med 1997;(Suppl 9):55.
215. Goldman MP, Fitzpatrick RE, Satur NM, Helena I. Treatment of congenital and acquired pigmented nevi with the Q-switched alexandrite, ruby, YAG, and pigmented lesion lasers. Lasers Surg Med 1995;(Suppl 7):48.
216. Vibhagool C, Byers HR, Grevelink JM. Treatment of small nevomelanocytic nevi with a Q-switched ruby laser. J Am Acad Dermatol 1997;36:738-41.
217. Imayama S, Ueda S. Long-and short-term histological observations of congenital nevi treated with the normal mode ruby laser. Arch Dermatol 1999;135;1211-8.
218. Tanaka H, Tsukuma H, Tomita S, Ajiki W, Kitagawa T, Kinoshita N. Time trends of incidence for cutaneous melanoma among the Japanese population: An analysis of Osaka. Cancer Registry data 1964-95. J Epidemiol 1999;9:S129-35.
219. Vinceti M, Bergomi M, Borciani N, Serra L, Vivoli G. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res 1999;9:97-103.
220. Zhu WZ, Kenealy J, Burd A, Gradidge T, Warr R, Rigby HS. Sublethal effects of exposing the human melanoma cell time Skmel-23 to 532 nm laser light. Int J Cancer 1997; 72:1104-12.
221. Van Leeuwen RL, Dekker SK, Byers HR, Vermeer BJ, Grevelink JM. Modulation of a4b1 and a5b1 integrin expression: Heterogeneous effects of Q-switched ruby, Nd:YAG, and alexandrite lasers on melanoma cells in vitro. Lasers Surg Med 1996;18:63-71.
222. Chan HH. Laser treatment of nevomelanocytic nevi: Can results from an asian study be applicable to the white population? Arch Dermatol 2002;138:535.
223. Ueda S, Imayama S. Normal-mode ruby laser for treating congenital nevi. Arch Dermatol 1997;133:355-9.
224. Lee PK, Rosenberg CN, Tsao H, Sober AJ. Failure of Q-swit switched ruby laser to eradicate atypical-appearing solar lentigo: Report of two cases. J Am Acad Dermatol 1998;38:314-7.
225. Kauvar AN, Geronemus RG. Treatment of lentigo maligna with a Q-switched ruby laser. Lasers Surg Med 1995; (Suppl 7):48.
226. Grekin RC, Shelton RM, Geisse JK, Frieden I. 510-nm pigmented lesion dye laser: Its characteristics and clinical uses. J Dermatol Surg Oncol 1993;18:341-7.
227. Acland KM, Barlow RJ. Lasers for the dermatologist. Br J Dermatol 2000;143:244-7.
228. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and post-inflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994;20:592-7.
229. Ross EV. Removal of termal pigment and tattoos: Can't we do better? En: Controversies and conversations in cutaneous laser surgery. Ojai (California) 2002;309-15.
230. Manaloto RM, Alster T. Erbium: YAG laser resurfacing for refractory melasma. Dermatol Surg 1999;25:121-3.
231. 2 laser followed by Q-switched alexandrite laser: A pilot study. Dermatol Surg 1999;25:494-7.
232. Bitter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835-42.
233. Weiss MA, Weiss RA, Costarangos C. Long term results 4 years using intense pulsed light for treatment of actinic changes including poikiloderma, telangiectasias and blotchy pigmentation. Lasers Surg Med 2001;(Suppl 13):81.
234. Watanabe S, Anderson RR, Brorson S, Dalickas G, Fujimoto JG, Flotte TJ. Comparative studies of femtosecond to microsecond laser pulses on selective pigmented cell injury in skin. Photochem Photobiol. 1991;53:757-62.
235. Bekhor PS. The role of pulsed laser in the management of cosmetically significant pigmented lesions. Austr J Dermatol 1995;36:221-3.
236. Tsao H, Busam K, Barnhill RL, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol 1996;132:1250-1.
237. Collins P, Cotterill JA. Minocycline induced pigmentation resolves after treatment with the Q-switched ruby laser. Br J Dermatol 1996;135:317-9.
238. Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyper-pigmentation. Arch Dermatol 1996;132:1251-2.
239. Green D, Friedman KJ. Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature. J Am Acad Dermatol 2001;44:342-7.
240. Wilde JL, English JC Finley EM. Minocycline-induced hyperpigmentation: Treatment with Nd:YAG laser. Arch Dermatol 1997;133:1344-6.
241. Karrer S, Hohenleutner U, Szeimies RM, Landthaler M. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol 1999;135:251-3.
242. Becker-Wegerich PM, Kuhn A, Malek L, Lehmann P, Megahed M, Ruzicka T. Treatment of nonmelanotic hyperpigmentation with the Q-switched ruby laser. J Am Acad Dermatol 2000;43;272-4.
243. Rüdlinger R. Ruby laser treatment for hyperpigmentation after cytotoxic therapy for AIDS-related Kaposi's sarcoma. Br J Dermatol 1998;138:924-7.
244. Atkin DH, Fitzpatrick RE. Laser treatment of imipramine-induced hyperpigmentation. J Am Acad Dermatol 2000; 43:77-80.
245. Trotter MJ, Tron VA, Hollingdale J, Rivers JK. Localized chrysiasis induced by laser therapy. Arch Dermatol 1995; 131:1411-4.
246. Dover JS, Arndt KA, Dinehart SM, Fitzpatrick RE, González E. Guidelines of care for laser surgery. J Am Acad Dermatol 1999;41:484-95.
247. Suh DH, Kwon TE, Youn JI. Changes of comedonal cytokines and sebum secretion after UV irradiation in acne patients. Eur J Dermatol 2002;12:139-44.
248. Mills OH, Kligman AM. Ultraviolet phototherapy and photochemotherapy of acne vulgaris. Arch Dermatol 1978; 114:221-3.
249. Mills OH, Porte M, Kligman AM. Enhancement of comedogenic substances by ultraviolet radiation. Br J Dermatol 1978;98:145-8.
250. Sigurdsson V, Knulst AC, Van Weelden H. Phototherapy of acne vulgaris with visible light. Dermatology 1997;194: 256-60.
251. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, et al. 5-aminolevulinic acid-based photodynamic therapy. Cancer 1997;79:2282-308.
252. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem Photobiol 1997;65:235-51.
253. Gilaberte Y. Terapia fotodinámica; fundamentos y aplicaciones generales. En: Cisneros Vela JL, Camacho Martínez F, editores. Láser y fuentes de luz pulsada intensa en dermatología y dermocosmética. Madrid: Aula Médica, 2000.
254. Bissonnette R, Lui H. Current status of photodynamic therapy in dermatology. Dermatol Clin 1997;15:507-19.
255. Pass HI. Photodynamic therapy in oncology: Mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-56.
256. Morton CA. Topical photodynamic therapy in dermatology. S Afr Med J 2001;91:634-7.
257. Boehncke WH, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994;343: 801.
258. Divaris DXG, Kennedy JC, Poittier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin fluorescence. Am J Pathol 1990;136:891-7.
259. Moan J. On the diffusion length of singlet oxygen in cells and tissue. J Photochem Photobiol Biol 1990;6:343-4.
260. Gilaberte Y, Pereboom D, Parapeto JF, Alda JO. Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin IX. Photodermatol Photoimmunol Photomed 1997;13:43-9.
261. Stillman S, Geen S, Harth Y, Shalita AR. High intensity narrow band blue light is effective in the treatment of acne vulgaris - an in vitro and in vivo study Journal of the European Academy of Dermatology and Venerelogy, 9th Congress, EADV, Genève 2000, Volume 14, Suppl 1, september 2000.
262. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthmjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115:183-92.
263. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001;144:575-9.
264. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. Acne phototherapy with a high-intensity, enhaced, narrow-band, blue light source: An open study and in vitro investigation. J Dermatol Sci 2002;30:129-35.
265. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 2000;142:973-8.
266. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinc acid. Arch Dermatol 2000;136;1093-5.
267. Lloyd JR, Mirkov M. Selective photothermolysis of the sebaceous glands for acne treatment. Lasers Surg Med 2002;31:115-20.
268. Ross EV, Blair MA, Saleh BA, Graham BS, Paithankar DY. Laser treatment of acne through selective dermal heating. ASLMS meeting. Atlanta, April 2002.
269. Paithankar DY, Ross EV, Saleh BA, Blair MA, Graham BS. Acne treatment with a 1450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med 2002;31:106-14.
270. Acland KM, Barlow RJ. Lasers for the dermatologist. Br J Dermatol 2000;143:244.
271. Cunliffe WJ, Goulden V. Phototherapy and acne vulgaris. Br J Dermatol 2000;142:855-6.
272. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002;146:178-88.
273. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. Br J Dermatol 2002;146:552-67.
274. Jacob CI, Dover JS, Kaminer MS. Acne scarring: A classification system and review of treatment options. J Am Acad Dermatol 2001;45:109-17.
275. Alster TS, McMeekin TO. Improvement of facial acne scars by the 585 nm flashlamp-pumped pulsed dye laser. J Am Acad Dermatol 1996;35:79-81.
276. Patel N, Clement M. Selective nonablative treatment of acne scarring with 585 nm flashlamp. En: Alora MB, Anderson RR, editors. Recent developments in cutaneous lasers. Lasers Surg Med 2000;26:108-18.
277. Vélez M, Cisneros JL. Fundamentos en fotodepilación. En: Láser y fuentes de luz pulsada intensa en dermatología y dermoscosmética. Madrid: Aula Médica, 2000; p. 175-90.
278. Ross V, Ladin Z, Kreindel M, Diericky C. Theoretical consideration in laser hair removal. Dermatol Clin 1999;17: 333-55.
279. Van Gemert MjC, Welch AJ. Time constants in thermal laser medicine. Lasers Surg Med 1989;9:405-21.
280. Goldberg DJ. Laser Hair Removal. London: Martin Dunitz, 2000.
281. Kilmer SL. Ama Press, 2002. Controversies and Conversations in Cutaneous Laser Surgery: Hair Removal for Lasers & light Sources in 2002. What's new? Personnal communication. Ojai (California), August 2002.
282. Radmanesh M, Mostaghimi M, Yousefi I, Mousavi ZB, Rasai S, Esmaili HR, et al. Leukotrichia developed following application of intense pulsed light for hair removal. Dermatol Surg 2002;28:572-4; (discussion 574).
283. Moreno-Arias GA, Castelo-Branco C, Ferrando J. Side-effects after IPL photodepilation. Dermatol Surg 2002;28:1131-4.
284. Moreno-Arias G, Castelo-Branco C, Ferrando J. Paradoxical Effect After IPL Photoepilation. Dermatol Surg 2002; 28:1013-6.
285. Goldberg DJ. Laser hair removal. Dermatol Clin 2002;20: 561-7.
286. Liew SH. Laser hair removal: Guidelines for management. Am J Clin Dermatol 2002;3:107-15.
287. Dierickx CC. Hair removal by lasers and intense pulsed light sources. Dermatol Clin 2002;20:135-46.
288. Alster TS. Laser-assisted hair removal: Recent advances in treating darker skin phototypes. Cosmet Dermatol 2000; 49-51.
289. Alster TS, Bryan H, Williams CM. Long-pulsed Nd:YAG laser-assisted hair removal in pigmented skin: A clinical and histologic evaluation. Arch Dermatol 2001;137:885-9.
290. Goldberg DJ, Silapunt S. Histologic Evaluation of a Millisecond Nd:YAG Laser for Hair Removal. Lasers Surg Med 2001;28:159-161.
291. Chui CT, Grekin RC, Leboit, PE, Zachary CB. Long-ppulsed Nd:YAG for hair removal: Histologic changes of the hair follicle after treatment. Disponible en: http.//www.lasernews.net, 1, 2000.
292. Diericx CC. Hair removal by lighyt: Accomplishments and challenges. Controversies and conversations in Cutaneous Laser Surgery. Chicago: Ama Press, 2002; p. 330-1.
293. Grossman MC, Dwyer P, Wimberley J, Flotte T, Anderon RR. Photodynamic Therapy for hirsutism. Lasers Surg Med 1995;7(Suppl):44.
294. Daly CH, Odland GF. Age-related changes in the mechanical properties of human skin. J Invest Dermatol 1979;73: 84-7.
295. Bernstein EF, Andersen D, Zelichson BD. Laser resurfacing for dermal photoaging. Clin Plast Surg 2000;27:221-40.
296. Frances C, Robert L. Elastin and elastic fibers in normal and pathologic skin. Int J Dermatol 1984:23:166-79.
297. Warren R, Gartsetin V, Kligman AM, Montagna W, Allendorf RA, Ridder GM. Age, sunlinght, and facial skin: A histologic annd quantitative study. J Am Acad Dermatol 1991; 25:751-60.
298. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol 1996;132:395-402.
299. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature sking aging induced by ultraviolet light. N Engl J Med 1997;337:1419-28.
300. Gilchrest BA. Treatment of photodamage with topical tretinoin: An overview. J Am Acad Dermatol 1997;36(Suppl): 27-36.
301. Fitzpatrick RE, Tope WD, Goldman MP, Satur NM. Pulsed carbon dioxide laser, tricholoacetic acid, BakerGordon phenol, and dermabrasion: A comparative clinical and histologic study of cutaneous resurfacing in a porcine model (letter;comments). Arch Dermatol 1996;132:469-71.
302. 2 laser on photoaged facial skin. Plast Reconstr Sur 1997;99:2036-50.
303. Hobbs ER, Bailin PL, Wheeland RG, Ratz JL. Superpulsed laser: Minimizing thermal damage with short pulse duration, high irradiance pulses. J Dermatol Surg Oncol 1987;13:955-64.
304. Pozner JN, Roberts TL III. Variable pulse width Er:YAG laser resurfacing. Clin Plast Surg 2000;27:263-71.
305. Weinstein C, Pozner JN, Ramírez OM. Complications of carbon dioxide laser resurfacing and their prevention. Aesthetic Surg J 1997;17:216-25.
306. Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-7.
307. Fulton J. Complications of laser resurfacing. Dermatol Surg 1997;24:91-9.
308. Nanni C, Alster T. Complications of carbon dioxide laser resurfacing. Dermatol Surg 1998;24:315-20.
309. Sriprachya-Anunt S, Fitzpatrick R, Goldman M, Smith SR. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997; 23:527-536.
310. Lowe N, Iask G, Griffin M, et al. Skin resurfacing with the UltraPulse arbon dioxide laser. Dermatol Surg 1995;21: 1025-9.
311. Khatri K, Ross V, Grevelink J, Magro GM, Anderson RR. Comparison of Er:YAG and carbon dioxide lasers in resurfacing of facial rhytides. Arch Dermatol 1999;135:391-7.
312. Bernstein LJ, Kauvar A, Grossman M, Geromemus RG. The short-and long-term side effects of carbon dioxide laser resurfacing. Dermatol Surg 1997;23:519-525.
313. Fitzpatrick RE. Laser resurfacing of thytides. Dermatol Clin 1997;15:431-47.
314. Hruza, GJ. Laser Skin Resurfacing. Arch Derm 1996;132: 451-5.
315. Teikameyer G, Goldberg D. Skin resurfacing with the Er:YAG laser. Dermatol Surg 1997;23:685-7.
316. Goldberg DJ. Er:YAG Laser Resurfacing: What is its role? Aest Surg J 1998;18:255-60.
317. Gilchrest BA, Rosen S, Noe JM. Chilling port wine stains improves the response to argon laser therapy. Plast Reconstr Surg 1982;69:278-83.
318. Nelson JS, Milner TE, Anvari B, Tanenbaum BS, Kimel S, Svaasand LO. Dynamic epidermal cooling during pulsed dye laser treatment of port wine stain: A new methodology with preliminary clinical evaluation. Arch Dermatol 1995; 131:695-700.
319. 2 laser promotes Repair of 3-Dimensional Elastic Fiber Network. Br J Dermatol 2001;144:452.
320. Ruiz Esparza J. Will laser resurfacing ever return to its glory days? Controversies and Conversations in Cutaneous laser Surgery. August 2002, Ojai (California) (comunicación personal).
321. Alster TS, West TB. Resurfacing of atrophic facial acne scars with a high-energy, pulsed carbon dioxide laser. Dermatol Surg 1996;22:151-4.
322. Alster TS, Garg S. Treatment of facial thytides with a high-energy pulsed carbon dioxide laser. Plast Reconstr Surg 1996;98:791-794.
323. Waldorf HA, Kauvar AN, Geronemus RG. Skin resurfacing of fine to deep rhytides using a charfree carbon dioxide laser in 47 patients. Dermatol Surg 1995;21:940-6.
324. Lask G, Keller G, Lowe N, Gormley D. Laser skin resurfacin with the SilkTouch flashscanner for facial rhytides. Dermatol Surg 1995;21:1021-4.
325. Lowe NJ, Lask G, Griffin ME, Maxwell A, Lowe P, Quilada F. Skin resurfacing with the ultrapulse carbon dioxide laser. Observations on 100 patients. Dermatol Surg 1995;21: 1025-9.
326. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol 1996;132:395-402.
327. Falabella R. Postdermabrasion leukoderma. J Dermatol Surg Oncol 1987;13:44-8.
328. 2 and Er:YAG laserskin resurfacing: What is the best approach? Controversies and Conversations in Cutaneous laser Surgery. (Colorado) Beaver Creek, 2001.
329. Khatri KA, Machado A, Magro C, Davenport S. Laser peel: Facial refuvenation with a superficial erbium:YAG laser treatment. J Cutan Laser Ther 2000;2:119-23.
330. Weiss RA, Harrington AC, Pfau RC, Weiss MA, Marwaha S. Periorbital skin resurfacing using high energy Er:YAG laser: Results in 50 patients. Lasers Surg Med 1999;24:81-6.
331. Zachary CB, Greken RC. Dual mode Er:YAG laser systems for sking resurfacing. LaserNews.net.January 2000;1. Available from: http//www.lasernews.net.
332. 2 laser system: A study in 102 patients. Br J Dermatol 2002;146:473-80.
333. Rasor JS, Antounian F, Glick JM. Multi- and single-elecrode electrosurgery for partial meniscectomy: Comparison of depth of injury and ablation rate, in Research Outcomes in Arthroscopy Surgery. Sunnyvale, CA, Arthrocare Corporation, 1995;1:1-9.
334. Burns RL, Carruthers A, Langtry JA, Trotter MJ. Electrosurgical skin resurfacing: The new bipolar instrument. Dermatol Surg 1999;25:582-6.
335. Tope W. Multielectrode radiofrequency resurfacing of ex-vivo human skin. Dermatol Surg 1999;25:348-52.
336. Herne KB, Zachary CB. New Facial Rejuvenation Techniques. Sem Cutan Med Surg 2000;19:221-31.
337. Grekin RG, Tope WD, Yardorough JM Jr, Olhoffer IH, Lee PK, Leffell DJ. Electrosurgical facial resurfacing. A prospective multicenter study of efficacy and safety. Arch Dermatol 2000;136:1309-16.
338. McDaniel DH, Ash K, Zukowski M. Treatment of stretch marks with the 585-nm flashlamp-pumped pulsed-dye laser. Dermatol Surg 1996;22:332-7.
339. Alster TS. Improvement of erythematous and hypertrophic scars by the 585 nm flashlamp-pumped pulsed dye laser. J Am Acad Dermatol 1996;35:79-81.
340. Zelickson B, Kist D. Pulsed dye laser and Photoderm treatment stimulates production of type-I collagen and collagenase transcripts in papillary dermis fibroblasts. Lasers Surg Med 2001;(Suppl 13):33.
341. Zelickson BD, Kilmer SL, Bernstein E, Chotzen KA, Dock J, Mehregan D. Pulsed dye laser for sun damaged skin. Lasers Surg Med 1999;25:229-36.
342. Zelickson BD, Coles C. Treatment of photodamaged skin usin long pulsed dye (595 nm). American Society for laser Medicine and Surgery. Personal communication. August 2002, Ojai (California).
343. Bjerring P, Clement M, Heickendorff L, Egevist H, Kiernan M. Selective non ablative wrinkle reduction by laser. J Cutan Laser Ther 2000;2:9-15.
344. Rostan E, Bowes LE, Iyer S, Fitzpatrick RE. A double-bind, side-by-side comparison study of low fluence long pulse dye laser to coolant treatment for wrinkling of the cheeks. J Cosmetic Laser Ther 2001;3:129-36.
345. Goldberg DJ, Whitworth J. Laser Skin Resurfacing with the Q-switched Nd:YAG Laser. Derm Surg 1997;23:903-7.
346. Goldberg DJ, Metzler C. Skin Resurfacing Utilizing a Lox-Fluence Nd:YAG Laser. J Cut Las Ther 1999;1:23-7.
347. Cisneros JL, Río R, Palou J. The Q-switched Nd:YAG laser with quadruple frequency. Clinical histological evaluation of facial resurfacing using different wavelenths. Dermatol Surg 1998;24:345-50.
348. Goldberg DJ, Samady J. Comparison of Intense Pulsed Light and Nd:YAG laser for Non-ablative Treatment of Facial Thytids. Laser Surg Med 2001;28:141-4.
349. Goldberg DJ. Non-ablative surbsurface remodeling: Clinical and histologic evaluation of a 1320 nm Nd:YAG laser. J Cut Las Ther 1999;1:153-7.
350. Goldberg DJ. Subdermal Resurfacing. Oper. Tech. In Oculopist, Orbital, and Reconstruc Surg 1999;2:188-93.
351. Goldberg DJ. Nonablative Resurfacing. Clin Plast Surg 2000;27:287-92.
352. Goldberg DJ. Full-Face Nonablative Dermal Remodeling with a 1320 nm Nd:YAG Laser. Dermatol Surg 2000;26: 915-8.
353. Fatemi A, Weiss MA, Weiss RA. Short-term histologic effects of nonablative resurfacing: Results with a dynamically cooled millisecond domain 1320 nm Nd:YAG laser. Dermatol Surg 2002;28:172-6.
354. Nelson JS, Millner TE, Dave D, et al. Clinical Study of non-ablative laser treatment of facial rhytides. Lasers Surg Med 1998;17(Suppl 9):150.
355. Goldberg DJ, Rogachefsky AS, Silapunt S. Non-ablative laser treatment of facial rhytides. Evaluation of a 1450 nm Diode laser with Dynamic cooling device. Lasers Surg Med 2001;21(Suppl 13):31.
356. Muccini J, O'Donnel F, Fuller T, Reinisch L. Laser treatment of solar elastosis with epithelial preservation. Lasers Surg Med 1998;23:121-7.
357. Fournier N, Dahan S, Barneon G, Diridollou S, Labarde JM, Gall Y. Nonablative remodeling: Clinical, histologic, ultrasound imagin, and profilometric evaluation of a 1540 nm Er:glass laser. Dermatol Surg 2001;27:799-806.
358. Goldman MP, Weiss RA. Treatment of poikiloderma of Civatrte on the neck with an intense pulsed light source. Plast Reconstr Surg 2001;107:1376-81.
359. Bitter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835-42 [discussion 843].
360. Weiss RA, Goldman MP, Weiss MA. Treatment of poikiloderma of Civatte with an intense pulsed light source. Dermatol Surg 2000;26:823-7 [discussion 828].
361. Sadick NS, Shea CR, Prieto VG. Effects of intense pulse light on sun-damaged human skin routine and ultrastructural analysis.American Society for laser medicine and Surgery. Personal communication. Ohio (California), August 2002.
362. Goldberg DJ, Cutler KB. Nonablative treatment of rhytids with intense pulsed light. Lasers Surg Med 2000;26:196-9.
363. Goldberg DJ. Histologic changes after treatment with an intense pulsed light. J Cut Las Ther 2000;2:53-6.
364. Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg 2001;27:627-31 [discussion 632].
365. Boixeda de Miquel P. Tratamiento de lesiones vasculares benignas con el láser de colorante pulsado a 585 nm. An Esp Pediatr 2000;51:3-5.
366. Onizuka K, Tsuneda K, Shibata Y, Ito M, Sekine Y. Efficacy of flashlamp-pumped dye laser therapy for port wine stains: Clinial assessment and histopathological characteristics. Br J Plast Surg 1995;48:271-9.
367. Fiskerstrand EJ, Svaasand LO, Kopstad G, Ryggen K, Aase S. Photothermally induced vessel wall necrosis after pulsed dye laser treatment lack of response in port wine stains with small sized or deeply located vessels. J Invest Dermatol 1996;107:671-5.
368. Van Gemert MJC, Nelson JS, Milner TE, Smithies DJ, Verkruysse W, De Boer JF, et al. Non-invasive determination of port wine stain anatomy and physiology for optimal laser treatment strategies. Phys Med Biol 1997;42:937-50.
369. Jacques SL, Nelson JS, Wright WH, Milner TE. Pulsed photothermal radiometry of port-wine-stain lesions. Appl Optics 1993;32:2439-46.
370. Nelson JS, Milner TE, Tanenbaum BS, Goodman DM, Van Gemert MJC. Infra-red tomography of port-wine-stain blood vessels in human skin. Lasers Med Sci 1996;11:199-204.
371. Schmitz CH, Oberheide U, Lohmann S, Lubatschowski H, Ertmer W. Pulsed photothermal radiometry as a metod for investigating blood vessel-like structures. J Biomed Opt 2001;6:214-23.
372. Nelson JS, Jacques SL, Wright WH. Determination of thermal and physical properties of port wine stain lesions using pulsed photothermal radiometry. SPIE 1992;1643:287-98.
373. Telenkov SA, Smithies DJ, Goodman DM, Tanenbaum BS, Nelson JS, Milner TE. Infrared imaging of in vivo microvasculature following pulsed laser irradiation. J Biomed Optics 1998;3:391-5.
374. Majaron B, Verkruysse W, Tanenbaum BS, Milner TE, Telenkov SA, Goodman DM, et al. Combining two excitation wavelengths for pulsed photothermal profiling of hypervascular lesions in human skin. Phys Med Biol 2000;45: 1913-22.
375. Nelson JS, Kelly KM, Zhao Y, Chen Z. Imaging blood flow in human port-wine stain in situ and in real time using optical Doppler tomography. Arch Dermatol 2001;137:741-4.
376. Chen Z, Milner T, Srinivas S, Wang X, Malekafzali A, Van Gemert MJC, et al. Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography. Optics Lett 1997;22:1119-21.
377. Barton KJ, Izatt JA, Kulkarni MD, Yazdanfar S, Welch AJ. Three-dimensional reconstruction of blood vessels from in vivo color Doppler optical coherence tomography images. Dermatology 1999;198:355-61.
378. Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. In vivo confocal laser scanning microscopy of human skin: Melanin provides strong contrast. J Invest Dermatol 1995;104:946-52.
379. Rajadhyaksha M, González S, Zavislan JM, Anderson RR, Webb RH. In vivo confocal scanning laser microscopy of human skin II: Advances in instrumentation and comparison with histology. J Invest Dermatol 1999;113:293-303.
380. González S, Tannous Z. Real-time, in vivo confocal reflectance microscopy of basal cell carcinoma. J Am Acad Dermatol 2002;47:869-74.
381. González S, Rajadhyaksha M, Rubinstein G, Anderson RR. Characterization of psoriasis in vivo by reflectance confocal microscopy. J Med 1999;30;337-56.
382. González S, Rajadhyaksha M, González-Serva A, White WM, Anderson RR. Confocal reflectance imaging of foliculitis in vivo; correlation with routine histology. J Cutan Pathol 1999;26:201-5.
383. González S, González E, White WM, Rajadhyaksha M, Anderson RR. Allergic contact dermatitis. Correlation of in vivo confocal imaging to routine histology. J Am Acad Dermatol 1999;40:708-13.
384. Hongcharu W, Dwyer P, González S, Anderson RR. Confirmation of onychomycosis by in vivo confocal microscopy. J Am Acad Dermatol 2000;42:214-6.
385. Goldgeier M, Fox CA, Muhlbauer JE. Immediate noninvasive diagnosis of herpesvirus by confocal scanning laser microscopy. J Am Acad Dermatol 2002;46:783-5.
386. González S, White WM, Rajadhyaksha M, Anderson RR, González E. Confocal imaging of sebaceous gland hyperplasia in vivo to assess efficacy and mechanism of pulsed dye laser treatment. Lasers Surg Med 1999;25:8-12.
387. Aghassi D, Anderson RR, González S. Confocal laser microscopic imaging of actinic keratoses in vivo: A preliminary report. J Am Acad Dermatol 2000;43:42-8.
388. Langley RGB, Rajadhyaksha M, Dwyer PJ, Sober AJ, Flotte TJ, Anderson RR. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo. J Am Acad Dermatol 2001;45:365-76.
389. Bussam KJ, Hester K, Charles C, Sachs DL, Antonescu C, González S, et al. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy. Arch Dermatol 2001; 137:923-9.
390. Rohrer T. The use of confocal microscopy in Mohs micrographic surgery (abstract). Lasers Surg Med 2000;3-4.
391. Sauermann K, Gambichler T, Jaspers S, Radenhausen M, Rapp S, Reich S, et al. Histometric data obtained by in vivo confocal laser scanning microscopy in patients with systemic sclerosis. BMC Dermatol 2002;2:8.
392. Aghassi D, Anderson RR, González S. Time-sequence histologic imaging of laser-treated cherry angiomas with in vivo confocal microscopy. J Am Acad Dermatol 2000;43: 37-41.
393. Vaccaro M, Magaudda L, Cutroneo G, Trimarchi F, Barbuzza O, Guarneri F, et al. Changes in the distribution of laminin alpha1 chain in psoriatic skin: Immunohistochemical study using confocal laser scanning microscopy. Br J Dermatol 2002;146:392-8.
394. Kazama T, Yamamoto Y, Hashimoto T, Komai A, Ito M. Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. Br J Dermatol 1998;138:593-601.
395. Rajadhyaksha M, Menaker G, Flotte T, Dwyer PJ, González S. Confocal examination of nonmelanoma cancers in thick skin excisions to potentially guide mohs micrographic surgery without frozen histopathology. J Invest Dermatol 2001;117:1137-43.
396. Asawanonda P, Anderson RR, Taylor CR. Pendulaser carbon dioxide resurfacing laser versus electrodesiccation with curettage in the treatment of isolated, recalcitrant psoriatic plaques. J Am Acad Dermatol 2000;42:660-6.
397. Hern S, Allen MH, Sousa AR, Harland CC, Barker JN, Levick JR, et al.
398. Lanigan SW, Katugampola GA. Treatment of psoriasis with the pulsed dye laser. J Am Acad Dermatol 1997;37:288-9.
399. Zelickson BD, Mehregan DA, Wendelschfer-Crabb G, Ruppman D, Cook A, O'Connell P, et al. Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. J Am Acad Dermatol 1996;35:64-8.
400. Feldman SR. Remissions of psoriasis with excimer laser treatment. Dermatol Online J 2002;8:23.
401. Trehan M, Taylor CR. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002;47:701-8.
402. Rodewald EJ, Housman TS, Mellen BG, Feldman SR. Follow-up survey of 308-nm laser treatment of psoriasis. Lasers Surg Med 2002;31:202-6.
403. Mafong EA, Friedman PM, Kauvar AN, Bernstein LJ, Alexiades-Armenakas M, Geronemus RG. Treatment of inverse psoriasis with the 308 nm excimer laser. Dermatol Surg 2002;28:530-2.
404. Feldman SR, Mellen BG, Housman TS, Fitzpatrick RE, Geronemus RG, Friedman PM, et al. Efficacy of the 308-nm excimer laser for treatment of psoriasis: Results of a multicenter study. J Am Acad Dermatol 2002;46:900-6.
405. Novak Z, Bonis B, Baltas E, Ocsovszki I, Ignacz F, Dobozy A, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. Photochem Photobiol B 2002;67:32-8.
406. Trehan M, Taylor CR. High-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002; 46:732-7.
407. Spann CT, Barbagallo J, Weinberg JM. A review of the 308-nm excimer laser in the treatment of psoriasis. Cutis 2001;68:351-2.
408. Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308-nm excimer laser for the treatment of psoriasis: A dose-response study. Arch Dermatol 2000;136:619-24.
409. Bissonnette R, Zeng H, McLean DI, Korbelik M, Lui H. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol 2001;74:339-45.
410. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. Br J Dermatol 2002;146:552-67.
411. Ruiz-Esparza J. Clinical response of psoriasis to low-energy irradiance with the Nd:YAG laser at 1320 nm report of an observation in three cases. Dermatol Surg 1999;25:403-7.
412. Chatrath V, Rohrer TE. Granuloma faciale successfully treated with long-pulsed tunable dye laser. Dermatol Surg 2002;28:527-9.
413. 2. Actas Dermosifiliogr 2001;92:244-6.
414. Cliff S, Félix RH, Singh L, Harland CC. The successful treatment of lupus pernio with the flashlamp pulsed dye laser. J Cutan Laser Ther 1999;1:49-52.
415. Greve B, Raulin C. Treating REM syndrome with the pulsed dye laser. Lasers Surg Med 2001;29:248-51.
416. 2 silk touch laser. Hautarzt 2000;51:5024.
417. Greve B, Hartschuh W, Raulin C. Extragenital lichen sclerosus et atrophicus - treatment with pulsed dye laser. Hautarzt 1999;50:805-8.
418. Kuhn A, Becker-Wegerich PM, Ruzicka T, Lehmann P. Successful treatment of discoid lupus erythematosus with argon laser. Dermatology 2000;201:175-7.
419. Greve B, Hartschuh W, Raulin C. Lichenoid dermatitis-treatment with pulsed dye laser: A case study. Lasers Surg Med 2002;31:23-6.
420. Alster TS, Manaloto RM. Nodular amyloidosis treated with a pulsed dye laser. Dermatol Surg 1999;25:133-5.
421. Woo PN, Finch TM, Hindson C, Foulds IS. Nodular prurigo successfully treated with the pulsed dye laser. Br J Dermatol 2000;143:215-6.
422. Liu HT. Treatment of lichen amyloidosis (LA) and disseminated superficial porokeratosis(DSP) with frequency-doubled Q-switched Nd:YAG laser. Dermatol Surg 2000;26: 958-62.
423. Kaufman AJ. Treatment of elastosis perforans serpiginosa with the flashlamp pulsed dye laser. Dermatol Surg 2000; 26:1060-2.
424. Clark SM, Mills CM, Lanigan SW. Treatment of keratosis pilaris atrophicans with the pulsed tunable dye laser. J Cutan Laser Ther 2000;2:151-6.
425. Fosko SW, Glaser DA, Rogers CJ. Eradication of angiolymphoid hyperplasia with eosinophilia by copper vapor laser. Arch Dermatol 2001;137:863-5.
426. Gupta G, Munro CS. Angiolymphoid hyperplasia with eosinophilia: Successful treatment with pulsed dye laser using the double pulse technique. Br J Dermatol 2000; 143:214-5.
427. Tanzi E, Alster TS. Pulsed dye laser treatment of multiple eccrine hidrocystomas: A novel approach. Dermatol Surg 2001;27:898-900.
428. Moreno-Arias GA, Camps-Fresneda A. Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser. J Cosmet Laser Ther 2001;3:143-6.
429. Manuskiatti W, Tantikun N. Treatment of Trichostasis Spinulosa in Skin Phototypes III, IV, and V With an 800-nm Pulsed Diode Laser. Dermatol Surg 2003;29:85-8.
430. Pross EV, Cooke LM, Overstreet KA, Buttolph GD, Blair MA. Treatment of pseudofolliculitis barbae in very dark skin with a long pulse Nd:YAG laser. J Natl Med Assoc 2002;94:888-93.
431. Ross EV, Cooke LM, Timko AL, Overstreet KA, Graham BS, Barnette DJ. Treatment of pseudofolliculitis barbae in skin types IV, V, and VI with a long-pulsed neodymium: Yttrium aluminum garnet laser. J Am Acad Dermatol 2002; 47:263-70.
432. Yamauchi PS, Kelly AP, Lask GP. Treatment of pseudofolliculitis barbae with the diode laser. J Cutan Laser Ther 1999;1:109-11.
433. Ruiz-Rodríguez R, Sanz-Sánchez T, Córdoba S. Photodynamic photorejuvenation. Dermatol Surg 2002;28:742-4.